Navigation Links
Risk Management: Best Practices for Medical Device Profitability
Date:4/23/2008

FDAnews and Industry Directions Launch New Study

FALLS CHURCH, Va. and CUMMAQUID, Mass., April 23 /PRNewswire-USNewswire/ -- FDAnews and Industry Directions Inc., in close association with research analysis partner Cambashi Ltd, today invited medical device manufacturers to respond to a new survey on current industry challenges and practices. The survey asks about company objectives, business processes and practices, information systems and applications, and performance.

The research team is seeking responses from all companies in the medical device industry -- of all sizes, all classes of devices, and in every geographic region. The initial online survey is open for industry response from now until early May. All responses will be aggregated to formulate report findings. Individual responses will remain strictly confidential.

The results of this survey will be released at the Fifth Annual Medical Device Quality Congress June 25-27 in Cambridge, MA in a special session on the research, Risk Management: Best Practices for Medical Device Profitability. This research ties in closely with this year's conference theme, Leading the Way to Better Performance With Quality Systems Compliance.

The study findings will be used by medical device manufacturers and others serving the industry to improve their performance and reduce business risk. The study will assess and identify opportunities for streamlining practices so manufacturers can achieve quality and regulatory compliance while increasing profit and growth.

The online survey is available at: http://www.surveymethods.com/EndUser.aspx?F4D0BCA5F6BEA6A6 or through http://www.fdanews.com or http://www.industrydirections.com. The survey is open to medical device manufacturers of all sizes worldwide. All survey respondents will receive a copy of the public findings report when it is released.

The research has been sponsored by five co-sponsor companies -- all of whom are active in the Medical Device sector. The analysis will be completed by Cambashi Ltd. and the report will be prepared independently by Industry Directions, which retains full editorial control.

The five co-sponsor companies underwriting the effort provide deep and diverse expertise in medical devices practices and provide production, quality, compliance, document management, and enterprise software to the industry. These companies are working together to increase the medical device market's understanding of how to reduce risks and improve compliance and profitability. Research sponsors for the study are: Camstar Systems (http://www.camstar.com ), IBS America (http://www.ibs-us.com), IQMS (http://www.iqms.com), MasterControl (http://www.mastercontrol.com) and Pilgrim Software (http://www.pilgrimsoftware.com).


'/>"/>
SOURCE FDAnews
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Records & Information Management: Are You Spending Right on Records Management, Data Security and Compliance?
2. Breast cancer prevention practices vary across Canada
3. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
4. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
5. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. Best Practice Database: Complimentary Excerpt of Pharma Quality Assurance Toolkit Available from Best Practices, LLC
8. Negative Publicity Around PFFS Sales Practices Not Getting Through to Seniors
9. Practices in Health & Disability Insurance - The Lives & Wealth They Cost America
10. The Scooter Store Wins Second Consecutive Best Practices Award From Runzheimer International
11. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the ... Insurance is sharing tips to make sure your family and vehicle are ready ... Safety Council, there may be 439 deaths and an additional 50,500 serious injuries from ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
Breaking Medicine Technology: